Currently, hypertension can be treated with a variety of synthetic angiotensin-converting enzyme (ACE) inhibitors, another enzyme that affects vascular function, either by converting angiotensin I to angiotensin II, which causes vasoconstriction [82], or by degrading bradykinin, a potent vasodilator [83]. This evidence concerns the gene ACE and hypertensive disorder.